Sign up to save your podcasts
Or
Share Updates from ACC 2023: Examining Transcatheter Repair Study Data
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Updates from ACC 2023: Examining Transcatheter Repair Study Data
Guest: Paul Sorajja, MD
TRILUMINATE was the first trial to take a look at the impact of tricuspid regurgitation (TR) reduction on patients, and its results may lead to significant improvements in care and quality of life. To learn more about this trial, Dr. Paul Sorajja from the Minneapolis Heart Institute Foundation details the key findings from this trial and explores their impact.
View all episodes
By ReachMDGuest: Paul Sorajja, MD
TRILUMINATE was the first trial to take a look at the impact of tricuspid regurgitation (TR) reduction on patients, and its results may lead to significant improvements in care and quality of life. To learn more about this trial, Dr. Paul Sorajja from the Minneapolis Heart Institute Foundation details the key findings from this trial and explores their impact.